DRUG-DRUG INTERACTION DATABASES: SENSITIVITY AND SPECIFICITY TO DETECT MANIFEST DRUG-DRUG INTERACTIONS, RELIABILITY RATINGS AND MANAGEMENT STRATEGIES OF POTENTIAL DRUG-DRUG INTERACTIONS

被引：0
|
作者：
Ocovska, Z. [1 ]
Marikova, M. [1 ]
Kukralova, K. [1 ]
Vlcek, J. [1 ]
机构：
[1] Charles Univ Prague, Fac Pharm Hradec Kralove, Hradec Kralove 521, Czech Republic
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 01期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
POSC204
引用
收藏
页码：S140 / S141
页数：2
相关论文
共 50 条
  • [31] Disagreement among drug compendia on inclusion and ratings of drug-drug interactions
    Fulda, TR
    Valuck, RJ
    Vander Zanden, J
    Parker, S
    Byrns, PJ
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2000, 61 (08): : 540 - 548
  • [32] Prevalence and predictors of potential drug-drug interactions
    Nikolic, Bozana
    Jankovic, Slobodan
    Stojanov, Oliver
    Popovic, Jovan
    CENTRAL EUROPEAN JOURNAL OF MEDICINE, 2014, 9 (02): : 348 - 356
  • [33] Indolealkylamines: Biotransformations and potential drug-drug interactions
    Yu, Ai-Ming
    AAPS JOURNAL, 2008, 10 (02): : 242 - 253
  • [34] EVALUATION OF POTENTIAL DRUG-DRUG INTERACTIONS WITH BARICITINIB
    Payne, C.
    Zhang, X.
    Shahri, N.
    Williams, W.
    Cannady, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1063 - 1063
  • [35] Potential drug-drug interactions in the outpatient setting
    Lafata, JE
    Schultz, L
    Simpkins, J
    Chan, KA
    Horn, JR
    Kaatz, S
    Long, C
    Platt, R
    Raebel, MA
    Smith, DH
    Xi, HG
    Yood, MU
    MEDICAL CARE, 2006, 44 (06) : 534 - 541
  • [36] DRUG-DRUG INTERACTIONS AS AN ISSUE IN DRUG DEVELOPMENT
    Jochemsen, R.
    Bouzom, F.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 105 : 2 - 2
  • [37] Therapeutic drug monitoring databases for postmarketing surveillance of drug-drug interactions
    Gex-Fabry, M
    Balant-Gorgia, AE
    Balant, LP
    DRUG SAFETY, 2001, 24 (13) : 947 - 959
  • [38] Drug-drug interactions in pharmacologic management of gastroparesis
    Youssef, A. S.
    Parkman, H. P.
    Nagar, S.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2015, 27 (11): : 1528 - 1541
  • [39] Therapeutic Drug Monitoring Databases for Postmarketing Surveillance of Drug-Drug Interactions
    Marianne Gex-Fabry
    Luc P. Balant
    Androniki E. Balant-Gorgia
    Drug Safety, 2001, 24 : 947 - 959
  • [40] Adverse drug reactions related to drug-drug interactions: lower severity level of drug-drug interactions and pharmacodynamic interactions are oversighted
    Kheloufi, F.
    Duval, M.
    Rouby, F.
    Ponte, J.
    Blin, O.
    Default, A.
    Micallef, J.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2018, 32 : 89 - 89
12345